Cohort effects in dynamic models and their impact on vaccination programmes: An example from Hepatitis A

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Srinivasa Rao, Arni S R ^a   Chen, Maggie H ^b   Pham, Ba'Z ^f   Tricco, Andrea C ^f   Gilca, Vladimir ^d,e   Duval, Bernard ^d,e   Krahn, Murray D ^c   Bauch, Chris T ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f GLAXOSMITHKLINE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; CANADA; COHORT ANALYSIS; COMPARTMENT MODEL; DISEASE TRANSMISSION; EFFECT SIZE; HEALTH PROGRAM; HEPATITIS A; HUMAN; INCIDENCE; INFECTION RATE; INFECTION RISK; LIFESPAN; MASS IMMUNIZATION; MORTALITY; RISK ASSESSMENT; RISK REDUCTION; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE FACTORS; CANADA; CHILD; CHILD, PRESCHOOL; COHORT EFFECT; COHORT STUDIES; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MIDDLE AGED; MODELS, BIOLOGICAL; SEROEPIDEMIOLOGIC STUDIES; TRAVEL;

EID: 33845775261     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-174     Document Type: Article

References (60)

1. Tapia-Conyer R, Santos JI, Cavalcanti AM, Urdaneta E, Rivera L, Manterola A, Potin M, Ruttiman R, Tanaka Kido J: Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg 1999, 61:825-829.
2. Gust ID: Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992, 10(Suppl 1):S56-S58.
3. Cuthbert JA: Hepatitis A: old and new. Clin Microbiol Rev 2001, 14:38-58.
4. Wasley A, Samandari T, Bell BP: Incidence of hepatitis A in the United States in the era of vaccination. J Am Med Soc 2005, 294(2):194-201.
5. Scheifele DW: Hepatitis A vaccines: the growing case for universal immunisation of children. Expert Opin Pharmacother 2005, 6:157-164.
6. Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW: Frequency of illness associated with epidemic hepatitis A virus infection in adults. Am J Epidemiol 1985, 122:226-233.
7. Bell BP, Feinstone SM: Hepatitis A vaccine. In Vaccines 4th edition. Edited by: Plotkin SA, OWA. Philadelphia, PA: Saunders; 2004:269-298.
8. Koff RS: Seroepidemiology of hepatitis A in the United States. J Infect Dis 1995, 171(Suppl 1):S19-23.
9. Almasio PL, Amoroso P: HAV infection in chronic liver disease: a rationale for vaccination. Vaccine 2003, 21:2238-2241.
10. Yao G: Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. In Viral Hepatitis and Liver Disease Edited by: Hollinger FB, Lemon SM, Margolis HS. Baltimore, MD, USA: Williams & Wilkins; 1991:76-78.
11. Jacobs RJ, Margolis HS, Coleman PJ: The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates. Arch Pediatr Adolesc Med 2000, 154:763-770.
12. Glickson M, Galun E, Orun R, Tur-Kaspa R, Shouval D: Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine 1992, 71:14-23.
13. Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention: Prevention of hepatitis A through active or passive immunization. Morb Mort Wkly Rep: Recommendations and Reports 1999, 48:1-37.
14. Public Health Agency of Canada (PHAC): Notifiable Diseases Online. [http://dsol-smed.hc-sc.gc.ca/dsol-smed/ndis/c_time_e.html].
15. Benenson MW, Takafuji ET, Bancroft WH, Lemon SM, Callahan MC, Leach DA: A military community outbreak of hepatitis type A related to transmission in a child care facility. Am J Epidemiol 1980, 112:471-481.
16. Hadler SC, Webster HM, Erben JJ, Swanson JE, Maynard JE: Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med 1980, 302:1222-1227.
17. Gingrich GA, Hadler SC, Elder HA, Ash KO: Serologic investigation of an outbreak of hepatitis A in a rural day-care center. Am J Public Health 1983, 73:1190-1193.
18. Pavia AT, Nielsen L, Armington L, Thurman DJ, Tierney E, Nichol CR: A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin. Am J Epidemiol 1990, 131:1085-1093.
19. Staes CJ, Schlenker TL, Risk I, Cannon KG, Harris H, Pavia AT, Shapiro CN, Bell BP: Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics 2000, 106(4):E54.
20. Centers for Disease Control and Prevention (CDC): Hepatitis Surveillance Report 2000, 57:.
21. Public Health Agency of Canada (PHAC): Canadian Immunization Guide. 6th edition. 2000 [http://www.phac-aspc.gc.ca/publicat/ciggci/].
22. Harb J, Lem M, Fyfe M, Patrick D, Ochnio J, Dobson S, Hockin J: Hepatitis A in the Northern interior of British Columbia: An outbreak among members of a first nations community. Health Canada Canada Comm Dis Rep 26(19):. 1 October 2000
23. Hockin J: Hepatitis A outbreak in a socially-contained religious community in rural southern Ontario. Health Canada Canada Comm Dis Rep 23(21):. 1 November 1997
24. Naus M, Everett W, Davies S, Coutts J: A school outbreak of hepatitis A in southwestern Ontario. Can Dis Wkly Rep 15(45):225-228. 1 November 1989
25. Deshaies D: Immunization against Hepatitis A during an Outbreak in a Jewish Orthodox Community-Quebec, 1997-1998. Health Canada Canada Comm Dis Rep 24(18):. 15 September 1998
26. De Serres G, Duval B, Shadmani R, Boulianne N, Pohani G, Naus M, Fradet MD, Rochette L, Ward BJ, Kain KC: Ineffectiveness of the current strategy to prevent hepatitis A in travelers. J Travel Med 2002, 9(1):10-16.
27. Ochnio JJ, Scheifele DW, Ho M: Hepatitis A virus in urban children - are preventative opportunities being missed? J Inf Dis 1997, 176:1610-1613.
28. Honish L: Hepatitis A Infected Food Handler at an Edmonton, Alberta Retail Food facility: Public Health Protection Strategies. Heath Canada CCDR 27(21):. 1 November 2001
29. Thompson L, McArthur B, Dalich-Adair T, Bell A: Hepatitis A outbreak in Grand Forks, British Columbia, 1990. Can Dis Wkly Rep 17(37):201-204. 14 September 1991
30. Minuk GY, Ding LX, Hannon C, Sekla K: The risks of transmission of acute hepatitis A and B virus infection in an urban centre. J Hepatol 1994, 21:118-121.
31. Armstrong GL, Bell BP: Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 2002, 109:839-845.
32. Muensch H: Catalytic models in epidemiology Cambridge, Massachussetts: Harvard University Press; 1959.
33. Pham B, Duval B, DeSerres G, Gilca V, Tricco AC, Ochnio J, Scheifele DW: Seroprevalence of hepatitis A infection in a lower endemicity country: a systematic review. BMC Inf Dis 2005, 5:56-67.
34. Jacobsen KJ, Koopman JS: The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidem 2005, 34:600-609.
35. Wong KH, Liu YM, Ng PSP, Young BWY, Lee SS: Epidemiology of Hepatitis A and Hepatitis E infection and their determinants in adult Chinese community in Hong Kong. J Med Virology 2004, 72:538-544.
36. Sattenspiel L, Simon CP: The spread and persistence of disease in structured populations. Math Biosci 1998, 90:341-366.
37. Diel R, Rappenhoener B, Schneider S: Cost-effectiveness of hepatitis A immunization of children and adolescents in Germany. Health Econ in Prev and Care 2001, 2:96-103.
38. Samandari T, Bell BP, Armstrong GL: Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine 2004, 22:4342-4350.
39. Anderson RM, May RM: Infectious diseases of humans: dynamics and control Oxford: Oxford University press; 1991.
40. Bauch CT, Earn DJD: Transients and attractors in epidemics. Proc R Soc Lond B 2003, 270:1573-1578.
41. Grassly NC, Fraser C, Garnett G: Host immunity and synchronized epidemics of syphilis across the United States. Nature 2005, 433:417-421.
42. Babad HR, Nokes DJ, Gay NJ, Miller E, Morgan-Capner P, Anderson RM: Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect 1995, 114(2):319-344.
43. Ministry of Health of New Zealand: Modelling Measles: Predicting and preventing measles epidemics in New Zealand. Application of a mathematical model Wellington: Ministry of Health; 1998.
44. Goldrick BA: Another vaccine preventable disease continues to emerge. Am J Nursing 2004, 104:27-28.
45. Leach C: Hepatitis A in the United States. Pediatric Infec Dis J 2004, 23:551-2.
46. Craig AS, Schaffner W: Prevention of hepatitis A with the hepatitis A vaccine. New Engl J Med 2004, 350:476-481.
47. Jacobs RJ, Gibson GA, Meyerhoff AS: Cost-effectiveness of Hepatitis A-B Vaccine Versus Hepatitis B Vaccine for Healthcare and Public Safety Workers in the Western United States. Inf Control and Hosp Epidem 2004, 25(7):563-569.
48. Centers for Disease Control and Prevention: Viral Hepatitis Surveillance Programme, 1983-1989.
49. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, Suntayakorn S, Suknuntapong T, Safary A, Tang DB: Protection against hepatitis A by an inactivated vaccine. J Am Med Assoc 1994, 271:1328-1334.
50. Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G: A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992, 327:453-457.
51. Statistics Canada: Canadian Statistics Section, Vital Statistics. [http://www.statscan.ca].
52. Statistics Canada: CANSIM Table 427-0003 and historical supplement 66-201. [http://cansim2.statcan.ca].
53. Duval B, Boucher F, Dion J, Dupont M, Robinson E, Tremblay M, Venne S, Willems B: Controle de l'hépatite A par l'immunisation au Quebec (Final Report, in French), Quebec Immunization Committee, December 1997.
54. el Saadany S, Gully P, Giulivi A: Hepatitis A, B, and C in Canada. Results from the National Sentinel Health Unit Surveillance System, 1993-1995. Can J Public Health 2002, 93(6):435-438.
55. Gosselin C, De Serres G, Rouleau I, Duval B, Shadmani R, Naus M, Ward BJ: Comparison of trip characteristics of children and adults with travel-acquired Hepatitis A infection. Ped Inf Dis J 2006, 25(12):1184-1186.
56. McFarlane ES, Embil JA, Manuel FR, Gorelick M: Prevalence of antibodies to hepatitis A antigen in patients attending a clinic for treatment of sexually transmitted disease. Sex Trans Dis 1980, 7:87-89.
57. Crewe MD, Embil JA, Garner JB: Prevalence of antibodies to hepatitis A virus in Nova Scotia children. Can Med Assoc J 1983, 25:1195-1197.
58. Payment P: Antibody levels to selected enteric virus in a French-Canadian population in the province of Quebec. Immunology and Inf Dis 1991, 1:317-322.
59. Blower SM, Dowlatabadi H: Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. International Statistical Review 1994, 62:229-243.
60. Golinski MR, Barany E, Ballyk M: Ecological conditions that favor the evolution of intermediate-virulence in an environmentally transmitted parasite. Journal of Mathematical Biology 2005, 51:389-402.